Merck (MRK) PT Lowered to $114 at Daiwa Securities

Go back to Merck (MRK) PT Lowered to $114 at Daiwa Securities

Morgan Stanley calls Merck (MRK) a 'Catalyst Driven Idea' ahead of ACC conference

February 14, 2023 12:41 PM EST

Morgan Stanley reiterated an Equal Weight rating and $99.00 price target on Merck & Co., Inc. (NYSE: MRK) ahead of the companys appearance at the ACC conference on Mar 6. MRK will present data from two pipeline CV drugs at the conference -... More